A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Nebivolol Added to Antihypertensive Treatment With Lisinopril or Losartan in Patients With Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 22 Mar 2013
At a glance
- Drugs Nebivolol (Primary) ; Lisinopril; Losartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 20 Jan 2011 Actual end date (March 2010) added as reported by ClinicalTrials.gov.
- 20 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History